According to the WHO, 1 in 4 people will be affected by mental illness or a neurological disorder at some point in their lives. It is no wonder, then, that neuroscience is one of the most heavily funded fields of science. A better understanding of neurological disease is critical, but the physiologic underpinnings are often complex. Researchers and instrumentation companies alike are stepping up to the challenge, improving the methods and tools used for neuroscience research and allowing for unprecedented discovery.
Data Sciences International’s (DSI) white paper, ‘In Vivo Research Approaches in the Study of Neurological Disease and Psychiatric Disorders’ provides a high level summary of key neurological disorders that are significant to today’s space, including:
- Alzheimer’s disease
- Epilepsy
- Mood disorders
- Traumatic Brain Injury
- Movement disorders
- Autism
- Schizophrenia
- Attention deficit hyperactivity disorder
For each illness, the white paper provides key background information, a list of suggested research references, and discusses key in vivo physiological endpoints, such as changes in EEG patterns, sleep abnormalities and respiratory failure. The final section of this paper describes essential technologies used in neuroscience research and how they can be used in tandem to study these physiologic endpoints of interest. These technologies include:
- Wireless telemetry
- Video-EEG
- Physiological data acquisition and analysis systems
- Software and hardware to measure and assess pulmonary function
- Software for sleep scoring and seizure detection
This white paper would be most valuable to researchers interested in learning more about how the most common neurological diseases and psychiatric disorders are studied, and what technologies are available to help them meet their research objectives.
Related Content
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition into Dementia Syndrome
In this webinar, Dr. Dennis Turner delves into dementia syndrome, the metabolic changes that occur, and the importance of proper physiological monitoring of animal models.
Vascular Contributions to Dementia
Ashley Walker, PhD discusses her research on the vascular contributions to late-onset Alzheimer’s disease and dementia.
Microvascular & Functional Ultrasound Imaging: Insights into Stroke and Neurovascular Diseases
Dr. Franck Lebrin and Dr. Denis Vivien discuss functional ultrasound imaging and its application to the study and treatment of stroke and other neurological diseases.
Optogenetic Stimulation for Parkinson’s Research: Recovering Movement in an Animal Model
Join Louise Parr-Brownlie, PhD and Conor Underwood, PhD for a review of implantable optogenetics to replace deep brain stimulation, a surgical procedure overview, and a discussion about the impact of acute optogenetic stimulation for the treatment of Parkinson's disease in a rat model.
Cutting Edge Conversations: Fighting Neurodegenerative Diseases
Evelyn Pyper, MPH, discusses how a patient-centered approach to real-world data collection and evidence generation can transform research in neurodegeneration.
Electrophysiology of Human Native Receptors in Neurological and Mental Disorders
Dr. Agenor Limon presents research integrating functional metrics with large anatomical, transcriptomic, and proteomic datasets to evaluate the relationship between synaptic E/I ratio and behavioral abnormalities across postmortem intervals and brain banks.
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling – Comparison of cOFM and Microdialysis
Dr. Joanna Hummer and Dr. Florie Le Prieult share insights into cOFM's use and utility in the broader neuroscience field and specifically for the development of drugs for neurodegenerative diseases.
Improving Sleep to Slow the Progression of Alzheimer’s Disease
Join Rohan Jagirdar, PhD as he discusses his research on EEG activity in a mouse model of Alzheimer's disease to determine the effects of improved sleep on disease progression.
EEG Monitoring Approaches to Predict Learning and Memory Changes in Early Alzheimer’s Disease
Dr. Fiona Harrison discusses how dietary deficiency and exposure to toxins can impact glutamate uptake and clearance, and the subsequent changes in neural signaling can be detected through altered EEG activity and performance on learning and memory tasks.